Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02703272 |
|---|---|
| Brief Title: | A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma |
| First Submitted : | March 3, 2016 |
| First Submitted that Met QC Criteria : | March 3, 2016 |
| First Posted : | March 9, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 27, 2021 |
| Last Update Posted : | May 28, 2021 |